Progression of Alzheimer's disease in black and white patients: The CERAD experience, part XVI

Neurology

Volumn 51, Issue 1, 1998, Pages 154-158

  Fillenbaum, Gerda G ^a,b   Peterson, B ^b   Welsh Bohmer, K A ^c   Kukull, W A ^d   Heyman, A ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CLINICAL FEATURE; DISEASE COURSE; EDUCATION; HUMAN; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM;

EID: 0031846601     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.154     Document Type: Article

References (31)

1. Harrell LE, Callaway R, Powers S. Autopsy in dementing illness: who participates? Alzheimer Dis Assoc Disord 1993;7: 80-87.
2. Ballard EL, Nash F, Raiford K, Harrell LE. Recruitment of black elderly for clinical research studies of dementia: The CERAD experience. Gerontologist 1993;33:561-565.
3. Goering S. Women and underserved populations: access to clinical trials. In: Dula A, Goering S, eds. "It just ain't fair": The ethics of health care for African Americans. Westport, CT: Praeger, 1994:182-192.
4. Welsh K, Ballard E, Nash F, Raiford K, Harrell L, Heyman A. Issues affecting minority participation in research studies of Alzheimer's disease. Alzheimer Dis Assoc Disord 1994;8(suppl 4):38-48.
5. De la Monte SM, Hutchins GM, Moore GW. Racial differences in the etiology of dementia and frequency of Alzheimer's lesions in the brain. J Nat Med Assoc 1989;81:644-652.
6. Folstein MF, Bassett SS, Anthony JC, Romanoski AJ, Nestadt GR. Dementia: case ascertainment in a community survey. J Gerontol Med Sci 1991;46:M132-M138.
7. Hendrie HC, Osuntokun BO, Hall KS, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 1995; 152:1485-1492.
8. Heyman A, Fillenbaum G, Prosnitz B, Raiford K, Burchett B, Clark C. Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol 1991;48: 594-598.
9. Schoenberg BS, Anderson DW, Haerer AV. Severe dementia: prevalence and clinical features in a biracial U.S. population. Arch Neurol 1985;42:740-743.
10. Cohen CI, Carlin J. Racial differences in clinical and social variables among patients evaluated in a dementia assessment center. J Nat Med Assoc 1993;85:379-384.
11. Cohen D, Eisdorfer C, Gorelick P, et al. Psychopathology associated with Alzheimer's disease and related disorders. J Gerontol Med Sci 1993;48:M255-M260.
12. Fabrega H, Mezzich J, Ulrich RF. Black-white differences in psychopathology in an urban psychiatric population. Compr Psychiatry 1988;29:285-297.
13. Welsh K, Fillenbaum G, Wilkinson W, Heyman A, Mohs RC, Stern Y. Neuropsychological test performance in African American and white patients with Alzheimer's disease. Neurology 1995;45:2207-2211.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
15. Morris JC, Heyman A, Mohs R, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment in Alzheimer's disease. Neurology 1989;39:1159-1165.
16. Morris JC, Edland S, Clark CM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change, a longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457-2465.
17. Mirra SS, Heyman A, McKeel DW, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-486.
18. Hughes CP, Berg L, Danziger W, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
19. Rosen WG. Verbal fluency in aging and dementia. J Clin Neuropsychol 1980;2:135-146.
20. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive status of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
23. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983;140:734-739.
24. Blessed G, Tomlinson B, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
25. Blazer DG, Landerman LR, Fillenbaum G, Horner R. Barriers to health services for older adults in the rural south. Am J Public Health 1995;85:1384-1390.
26. Lipkind KL. National hospital ambulatory medical care survey: 1993 outpatient department summary. Advance data from vital and health statistics, no. 268. Hyattsville, MD: National Center for Health Statistics, 1995.
27. Lichtenberg PA, Ross T, Christensen B. Preliminary normative data on the Boston Naming Test for an older urban population. Clin Neuropsychol 1994;8:109-111.
28. Murden RA, McRae TD, Kanes S, Bucknam ME. Mini-Mental State exam scores vary with education in blacks and whites. J Am Geriatr Soc 1991;39:149-155.
29. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40: 922-935.
30. Fillenbaum GG, Huber MS, Beekly BS, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIII. Obtaining autopsy in Alzheimer's disease. Neurology 1996;46:142-145.
31. Heyman A, Peterson B, Fillenbaum G, Pieper C. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part XIV. Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 1996;46:656-660.